International Patent: ORAL PHARMACEUTICAL COMPOSITION COMPRISING CDK4/6 AND DYRK2 DUAL-TARGET INHIBITOR ACTIVE INGREDIENTS AND PREPARATION METHOD FOR ORAL PHARMACEUTICAL COMPOSITION

GENEVA, July 2 -- JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/141210) for “ORAL PHARMACEUTICAL COMPOSITION COMPRISING CDK4/6 AND DYRK2 DUAL-TARGET INHIBITOR ACTIVE INGREDIENTS AND PREPARATION METHOD FOR ORAL PHARMACEUTICAL COMPOSITION”. With publication no. WO/2026/130175, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/506

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....